Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin [MVAC] versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer.

被引：12

作者：

Bamias, A.

Karadimou, A.

Lampaki, S.

Aravantinos, G.

Xanthakis, I.

Papandreou, C.

Lainakis, G.

Zagouri, F.

Soupos, N.

Kostouros, E.

Samantas, E.

Hatzimouratidis, C.

Konstantinidis, C.

Deliveliotis, C.

Pectasides, D. G.

Fountzilas, G.

Dimopoulos, M. A.

机构：

[1] Alexandra Peripheral Gen Hosp, Athens, Greece

[2] Univ Athens, Athens, Greece

[3] Hellen Cooperat Oncol Grp Data Off, Athens, Greece

[4] Univ Thessalia, Larisa, Greece

[5] Agioi Anargiroi Hosp, Athens, Greece

[6] Univ Thessaloniki, GR-54006 Thessaloniki, Greece

[7] Hellen Cooperat Oncol Grp HeCOG, Athens, Greece

来源：

关键词：

D O I：

10.1200/jco.2011.29.15_suppl.4510

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

4510

引用

页数：1